Fistuloplasty using a radiation-and-time-saving sheathless balloon catheter.


Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 16 10 2018
medline: 14 6 2019
entrez: 16 10 2018
Statut: ppublish

Résumé

Sheath placement in dialysis access interventions is traditionally necessary to obtain imaging, guide percutaneous angioplasty, and evaluate results. The aim of this study was to assess the feasibility of performing sheathless Arterio-venous (AV) access interventions using a novel percutaneous angioplasty balloon catheter. Between May and September 2017, data on all dialysis access interventions using a novel percutaneous angioplasty balloon with a dedicated injection port were collected. All procedures were performed without a sheath. Success was established as no conversion to sheath placement. Demographic data, location of lesion, time to perform procedure, amount of contrast used, radiation exposure, and access complications were recorded. Ultrasound was used to evaluate access site complications. Sheathless interventions were successful in 24 patients with the mean age of 62 years (29-94). There were 5 PTFE grafts and 19 native fistulas. Lesions were located anywhere from the arterial anastomosis to the cephalic arch. The average balloon size was 6 mm (5-7 mm), and the procedure time was 15.8 min (8-45 min). No access site complications were observed. Sheathless intervention is feasible with several potential advantages, including short procedure time, minimal contrast volume, and reduced radiation exposure. Finally, the lower profile at the access site may result in fewer complications.

Identifiants

pubmed: 30319012
doi: 10.1177/1129729818804991
pmc: PMC6507052
doi:

Substances chimiques

Polytetrafluoroethylene 9002-84-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-280

Références

Radiology. 2012 Jul;264(1):278-84
pubmed: 22550308
J Vasc Surg. 2016 Jan;63(1):198-203
pubmed: 26474506
J Vasc Access. 2016 Mar-Apr;17(2):103-10
pubmed: 26847736
Catheter Cardiovasc Interv. 2018 Jan 4;:null
pubmed: 29667719

Auteurs

Joel Crawford (J)

Stony Brook University Hospital, Stony Brook, NY, USA.

Angela Kokkosis (A)

Stony Brook University Hospital, Stony Brook, NY, USA.

Pamela Kim (P)

Stony Brook University Hospital, Stony Brook, NY, USA.

Antonios Gasparis (A)

Stony Brook University Hospital, Stony Brook, NY, USA.

Nicos Labropoulos (N)

Stony Brook University Hospital, Stony Brook, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH